EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives

Michał Walaszek iD, Wiesław Jerzy Cubała iD, Zofia Kachlik iD

Journal of Clinical Medicine · 25.12.2025 · 15 (1) · 150

DOI: 10.3390/jcm15010150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.12.2025. Verfasst von Michał Walaszek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, 80-214 Gdańsk, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Gdansk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment-resistant depression (TRD) remains a significant public-health challenge, with many patients failing to respond to conventional therapies. Ketamine has emerged as a rapid-acting intervention, but quantitative outcomes alone do not capture patients’ lived experiences, which shape engagement, acceptability, and adherence. We conducted a narrative review of qualitative and mixed-methods studies to enable conceptual integration and thematic synthesis of patients’ experiences with ketamine treatment for depression, guided by established narrative review methodology and the SANRA framework. A targeted search of MEDLINE and Scopus (November 2025) identified studies reporting adult patients’ perspectives on therapeutic ketamine or esketamine use, with qualitative data synthesized iteratively in keeping with narrative review principles. Across the literature, patients’ perspectives coalesce around key thematic domains, including motivations and expectations for treatment, the phenomenology of the treatment experience, post-treatment trajectories, side effects and reasons for discontinuation, relational and environmental factors, and information and education needs. By focusing on these thematic groups, the review highlights the experiential dimensions that influence the perceived value and acceptability of ketamine, underscoring the need for patient-centered service design. Integrating these insights can guide the development of ketamine programs that are both evidence-based and aligned with patients’ priorities and perspectives.

Schlagwörter

Stichwörter der Autor:innen

affective disordersketaminepatient perspectivespatient-reported outcomesqualitative researchtreatment-resistant depression

Autor:innen und Institutionen

  • Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, 80-214 Gdańsk, Poland.

ORCID-Profile: Michał Walaszek, Wiesław Jerzy Cubała, Zofia Kachlik

Förderung

  • Medical University of Gdansk

Zitieren

APA

Walaszek, M., Cubała, W. J., & Kachlik, Z. (2025). Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives. Journal of Clinical Medicine, 15(1), 150. https://doi.org/10.3390/jcm15010150

Vancouver

Walaszek M, Cubała WJ, Kachlik Z. Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives. Journal of Clinical Medicine. 2025;15(1):150. doi:10.3390/jcm15010150

BibTeX
@article{Walaszek2025,
  author = {Walaszek, Michał and Cubała, Wiesław Jerzy and Kachlik, Zofia},
  title = {Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {150},
  doi = {10.3390/jcm15010150}
}
Kostenlos starten →